4-propionyloxy-4-phenyl-n-methylpiperidine and verapamil

4-propionyloxy-4-phenyl-n-methylpiperidine has been researched along with verapamil in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cabot, MC; Cao, Ht; Geffen, V; Giuliano, AE; Han, TY; Lavie, Y; Lucci, A; Volner, A	1

Other Studies

1 other study(ies) available for 4-propionyloxy-4-phenyl-n-methylpiperidine and verapamil

Article	Year
Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells. The Journal of biological chemistry, 1997, Jan-17, Volume: 272, Issue:3 Topics: Ceramides; Cyclosporine; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glycosphingolipids; Glycosylation; Humans; Meperidine; Tamoxifen; Tumor Cells, Cultured; Verapamil	1997

Article

Year

Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells.

The Journal of biological chemistry, 1997, Jan-17, Volume: 272, Issue:3

Topics: Ceramides; Cyclosporine; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glycosphingolipids; Glycosylation; Humans; Meperidine; Tamoxifen; Tumor Cells, Cultured; Verapamil

1997